SCOTT WILKINSON DO NPI 1184812992

NPI Details

Scott Wilkinson, DO is an urology in Saint Clair Shores, MI with 21 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Scott Wilkinson, DO NPI is 1184812992. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MICHIGAN STATE UNIVERSITY COLLEGE OF OSTEOPATHIC MEDICINE
Graduation Year:2004

The provider's business location address is:

20952 E 12 MILE RD
SUITE 200
SAINT CLAIR SHORES, MI
ZIP 48081-200
Phone: (586) 771-4820
Fax: (586) 771-6620

The NPI 1184812992 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Liver function blood test panel (HCPCS:80076)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Testosterone (hormone) level, total (HCPCS:84403)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Vitamin d-3 level (HCPCS:82306)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Testosterone (hormone) level, free (HCPCS:84402)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound scan of scrotum (HCPCS:76870)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Complete ultrasound of abdomen and pelvis artery and vein blood flow (HCPCS:93975)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 10/5/2007 and was last updated on 2/1/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.